American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$493M |
| 2 |
Colgate-Palmolive
CL
|
+$367M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Fidelity National Information Services
FIS
|
+$298M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$268M |
| 3 |
Medtronic
MDT
|
+$233M |
| 4 |
Intercontinental Exchange
ICE
|
+$201M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Newmark Group
NMRK
$2.68B
| $3.5M | ﹤0.01% |
386,600
+88,948
| +30% | +$826K |
|
877
AudioCodes
AUDC
$249M
| $3.49M | ﹤0.01% |
184,482
-54,237
| -23% | -$975K |
|
878
Goosehead Insurance
GSHD
$2.33B
| $3.49M | ﹤0.01% |
70,643
-67,771
| -49% | -$3.11M |
|
|
BPFH
879
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.46M | ﹤0.01% |
297,139
+149,604
| +101% | +$1.68M |
|
|
LTRPA
880
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $3.42M | ﹤0.01% |
363,555
+4,113
| +1% | +$42.9K |
|
881
Green Dot
GDOT
$766M
| $3.38M | ﹤0.01% |
133,736
-169,892
| -56% | -$6.29M |
|
882
WIX.com
WIX
$2.88B
| $3.35M | ﹤0.01% |
28,651
+2,135
| +8% | +$297K |
|
883
UFP Industries
UFPI
$5.06B
| $3.34M | ﹤0.01% |
+83,803
| New | +$3.26M |
|
884
Horace Mann Educators
HMN
$2.09B
| $3.3M | ﹤0.01% |
71,198
+38,051
| +115% | +$1.66M |
|
885
Compañía de Minas Buenaventura
BVN
$8.79B
| $3.25M | ﹤0.01% |
213,957
-162,343
| -43% | -$2.52M |
|
|
QEP
886
DELISTED
QEP RESOURCES, INC.
QEP
| $3.24M | ﹤0.01% |
+876,318
| New | +$4.17M |
|
|
KYNB
887
Kyntra Bio
KYNB
$28.7M
| $3.19M | ﹤0.01% |
3,449
+204
| +6% | +$224K |
|
|
GBT
888
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.17M | ﹤0.01% |
65,318
+3,846
| +6% | +$200K |
|
889
AngioDynamics
ANGO
$651M
| $3.17M | ﹤0.01% |
171,849
-54,877
| -24% | -$1.07M |
|
890
Iridium Communications
IRDM
$5.26B
| $3.16M | ﹤0.01% |
148,684
-291,516
| -66% | -$6.95M |
|
|
EGRX
891
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.09M | ﹤0.01% |
54,660
+567
| +1% | +$31.9K |
|
|
FLXN
892
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.07M | ﹤0.01% |
223,684
+55,212
| +33% | +$655K |
|
|
NTUS
893
DELISTED
Natus Medical Inc
NTUS
| $3.06M | ﹤0.01% |
+96,270
| New | +$2.81M |
|
|
CSGS
894
DELISTED
CSG Systems International
CSGS
| $3.04M | ﹤0.01% |
+58,915
| New | +$3.02M |
|
895
Heron Therapeutics
HRTX
$64.7M
| $3.04M | ﹤0.01% |
164,055
+10,118
| +7% | +$186K |
|
896
Werner Enterprises
WERN
$2.27B
| $3.03M | ﹤0.01% |
85,839
-67,972
| -44% | -$2.21M |
|
|
NXGN
897
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.95M | ﹤0.01% |
+188,510
| New | +$3.14M |
|
898
Apple Hospitality REIT
APLE
$3.71B
| $2.95M | ﹤0.01% |
178,027
-54
| -0% | -$855 |
|
899
VanEck India Growth Leaders ETF
GLIN
$93.4M
| $2.95M | ﹤0.01% |
90,445
+47,308
| +110% | +$1.58M |
|
900
Sanmina
SANM
$11.2B
| $2.93M | ﹤0.01% |
91,335
+26,670
| +41% | +$818K |
|
Similar funds
American Century Companies's Q3 2019 Portfolio in Review
As of Q3 2019, American Century Companies held 1,407 positions worth $99.6B, down 0.83% from $100B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2019 filing shows 144 new, 546 increased, 497 reduced and 204 closed positions. Its largest new stake was A.O. Smith: 2,750,567 shares worth $131M. The largest sale was Worldpay, Inc., an estimated $300M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2019 buy was A.O. Smith: 2,750,567 shares worth $131M.
- American Century Companies added most to Pfizer in Q3 2019, an estimated $493M increase.
- American Century Companies's biggest Q3 2019 reduction was Medtronic, cutting an estimated $233M.
- American Century Companies fully exited Worldpay, Inc. in Q3 2019, selling an estimated $300M.
- American Century Companies's ten largest holdings make up 18% of its $99.6B portfolio in Q3 2019.
- American Century Companies opened 144 new positions and closed 204 in Q3 2019.
- American Century Companies's portfolio value fell 0.83% quarter-over-quarter to $99.6B.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.